FindTrial
Sign In

Study on optimal surgical strategy of macular hole in pathological myopia

Study on optimal surgical strategy of macular hole in pathological myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050159
Enrollment
Unknown
Registered
2021-08-19
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular hole in pathological myopia

Interventions

Amniotic membrane covering group:Amniotic membrane covering
Amniotic membrane tamponade group:Amniotic membrane tamponade

Sponsors

The Eye Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Myopic macular hole, with diopter > -6.0d, axis > 26.5mm, myopic macular lesion (classification 2 to 3, or combined with "Plus" damage not involving macular fovea), posterior scleral staphylostoma was present; 2. Patients aged >=18 years; 3. Able and willing to participate in clinical trials.

Exclusion criteria

Exclusion criteria: 1. Idiopathic macular hole; 2. Traumatic macular hole; 3. Myopic macular hole with other holes; 4. Myopic macular hole with retinal detachment; 5. Previous vitreoretinal surgery, posterior scleral reinforcement or posterior scleral belt surgery; 6. Not expected to be in the designated clinical trial center; 7. Having neurological or psychiatric diseases and unable to cooperate with the examination.

Design outcomes

Primary

MeasureTime frame
Macular hole closure rate;Best corrected visual acuity;—

Countries

China

Contacts

Public ContactWei Yong

The Eye Hospital of Wenzhou Medical University

weiyongdoctor@163.com+86 15057551266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026